Public-private Partnership Will Assess Therapy Potential, Effects of CBD episode artwork

EPISODE · Feb 12, 2021 · 9 MIN

Public-private Partnership Will Assess Therapy Potential, Effects of CBD

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a public-private partnership to assess the therapy potential and effects of CBD.Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Upper Body Health Also Is Important for People with MS”.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Feb 12, 2021

Embed this episode

NOW PLAYING

Public-private Partnership Will Assess Therapy Potential, Effects of CBD

0:00 9:17

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 9 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on February 12, 2021.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!